Page 49 - Read Online

Pavan et al. J Transl Genet Genom 2021;5:173-81 https://dx.doi.org/10.20517/jtgg.2021.18 Page 181

clinical staging based on urine collection following prostatic massage. Oncol Lett 2019;18:6917-25. DOI PubMed PMC
7. Connell SP, O'Reilly E, Tuzova A, et al. Development of a multivariable risk model integrating urinary cell DNA methylation and cell-
free RNA data for the detection of significant prostate cancer. Prostate 2020;80:547-58. DOI PubMed PMC
8. Zhao F, Vesprini D, Liu RSC, et al. Combining urinary DNA methylation and cell-free microRNA biomarkers for improved
monitoring of prostate cancer patients on active surveillance. Urol Oncol 2019;37:297.e9-297.e17. DOI PubMed
9. Silva R, Moran B, Russell NM, et al. Evaluating liquid biopsies for methylomic profiling of prostate cancer. Epigenetics 2020;15:715-
27. DOI PubMed PMC
10. Haldrup C, Pedersen AL, Øgaard N, et al. Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate
cancer tissue and liquid biopsies. Mol Oncol 2018;12:545-60. DOI PubMed PMC
11. Reis IM, Ramachandran K, Speer C, Gordian E, Singal R. Serum GADD45a methylation is a useful biomarker to distinguish benign vs
malignant prostate disease. Br J Cancer 2015;113:460-8. DOI PubMed PMC
12. Constâncio V, Nunes SP, Moreira-Barbosa C, et al. Early detection of the major male cancer types in blood-based liquid biopsies using
a DNA methylation panel. Clin Epigenetics 2019;11:175. DOI PubMed PMC
13. Menschikowski M, Jandeck C, Friedemann M, et al. Identification of rare levels of methylated tumor DNA fragments using an
optimized bias based pre-amplification-digital droplet PCR (OBBPA-ddPCR). Oncotarget 2018;9:36137-50. DOI PubMed PMC
14. Bjerre MT, Nørgaard M, Larsen OH, et al. Epigenetic analysis of circulating tumor DNA in localized and metastatic prostate cancer:
evaluation of clinical biomarker potential. Cells 2020;9:1362. DOI PubMed PMC
15. Beltran H, Romanel A, Conteduca V, et al. Circulating tumor DNA profile recognizes transformation to castration-resistant
neuroendocrine prostate cancer. J Clin Invest 2020;130:1653-68. DOI PubMed PMC
16. O'Reilly E, Tuzova AV, Walsh AL, et al. epiCaPture: a urine DNA methylation test for early detection of aggressive prostate cancer.
JCO Precis Oncol 2019;2019:PO.18.00134. DOI PubMed PMC
17. Carson JJK, Di Lena MA, Berman DM, Siemens DR, Mueller CR. Development and initial clinical correlation of a DNA methylation-
based blood test for prostate cancer. Prostate 2020;80:1038-42. DOI PubMed
18. Wu A, Cremaschi P, Wetterskog D, et al. Genome-wide plasma DNA methylation features of metastatic prostate cancer. J Clin Invest
2020;130:1991-2000. DOI PubMed PMC